BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17598865)

  • 1. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
    Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).
    El-Mofty M; El Weshahy H; Youssef R; Abdel-Halim M; Mashaly H; El Hawary M
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):38-42. PubMed ID: 18201356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
    Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
    J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
    Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
    Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Ayub Med Coll Abbottabad; 2005; 17(1):34-6. PubMed ID: 15929524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy.
    Evers AW; Kleinpenning MM; Smits T; Boezeman J; van de Kerkhof PC; Kraaimaat FW; Gerritsen MJ
    Br J Dermatol; 2009 Sep; 161(3):542-6. PubMed ID: 19538185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis.
    Buckley DA; Healy E; Rogers S
    Br J Dermatol; 1995 Sep; 133(3):417-22. PubMed ID: 8546997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial.
    Schiener R; Brockow T; Franke A; Salzer B; Peter RU; Resch KL
    Arch Dermatol; 2007 May; 143(5):586-96. PubMed ID: 17519218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
    Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
    Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
    Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis.
    Diette KM; Momtaz-T K; Stern RS; Arndt KA; Parrish JA
    Arch Dermatol; 1984 Sep; 120(9):1169-73. PubMed ID: 6476854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
    Kirby B; Buckley DA; Rogers S
    Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.